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Exposure of the fetus to cigarette smoke is an important, dose-
related and preventable risk factor in the quest for optimal
pregnancy outcome. It is therefore essential that all health care
workers and mothers are fully aware of these adverse effects. 
Nicotine, the dominant alkaloid in tobacco smoke, easily
crosses the placenta, leading to fetal plasma concentrations on
average 15% higher than those of the mother.1 Nicotine also
concentrates in placental tissue, amniotic fluid and breast-milk.
Amniotic nicotine levels in the mid-trimester are up to 54%
higher than those in maternal serum.  The swallowing of
amniotic fluid therefore increases fetal intake of nicotine. The
consequence is that fetuses of mothers who smoke are exposed
to relatively higher levels of nicotine than their mothers. Further
risks are added neonatally by maternal smoking during lactation
as the plasma/breast-milk nicotine ratio is 2.9.1 Therefore, it is
not surprising that nicotine has extensive effects on: (i) maternal
and fetal cardiovascular systems; (ii) uterine, umbilical and
cerebral blood flow; (iii) the developing cerebral cortex; (iv)
developing respiratory epithelium; and (v) fetal growth.
The adverse effect of nicotine is through its vasoconstrictive
effects on the uterine and potentially also on the umbilical
artery.1 It is of great concern that nicotine can activate nicotine
receptors in the fetal brain as this may affect brain development
and smoking patterns later in life.2
As we know today, the endothelium plays a much greater role
in health and disease than was ever thought to be the case 10
years ago. It has been shown that the free radical components of
cigarette smoke cause much of the damage.3 Even passive
smoking is associated with abnormal endothelial function.4 The
risk of passive smoking is comparable with that of a light
smoker in pregnancy.1
As far as the specific effect on the endothelium is concerned, it
seems that smoking during pregnancy is associated with
reduced cellular fibronectin and increased intracellular adhesion
molecule-1.5 In addition, it has been found that cigarette
smoking is associated with increased circulating levels of lipid
peroxidation products, which may contribute to endothelial
damage.
Carbon monoxide in cigarette smoke inhibits release of
oxygen to fetal tissues by creating carboxyhaemoglobin, which
induces relative tissue hypoxia.6 Microscopic examination of
placental tissue of smokers reveals thickening of the
trophoblastic membrane, hypertrophy and calcifications —
evidence of the response to hypoxia.7 At microvascular level,
delayed neutrophil transit has been described, which gives rise
to structural lung damage because of accumulation of cells in the
interstitium and bronchalveolar spaces. Lackman et al.8 showed
transplacental fetal exposure to two tobacco-specific carcinogens,
isolated from the urine of in utero exposed neonates.  The effects
of the other components of cigarette smoke, e.g. hydrogen
cyanide, thiocyanates and hydrocarbons, will not be addressed
here.
The harmful effects of fetal nicotine exposure are evident in all
trimesters of pregnancy.1 In the first trimester there is a 33%
increase in incidence of spontaneous abortion.  In the second
trimester there is a dose-dependent increase in preterm labour
and prematurity,8 and in the third trimester a doubled risk of
low birth weight.
In their five meta-analyses of the adverse effects of maternal
smoking, Castles et al.9 found a statistically significant increase in
the risks of abruptio placentae, placenta praevia, ectopic
pregnancy and preterm prelabour rupture of membranes. In
addition, maternal cigarette smoking has also been implied in
the aetiology of congenital defects, e.g. cleft lips and palates,10
neural tube defects, congenital cardiac defects, limb reduction
defects6 and anencephaly.1 Furthermore, smoking is associated
with an increase in childhood malignancies, including brain
tumours, leukaemia and lymphoma.11
The complications associated with maternal cigarette smoking
during the neonatal period include doubling the risk of sudden
infant death syndrome (SIDS)12 and restriction of pulmonary
maturation, leading to increased incidence of asthma and upper
respiratory infections in children.1 Follow-up of children who
suffered in utero cigarette smoke exposure showed negative
long-term cognitive outcomes, including behavioural disorders,
cognitive impairment relating to linguistic skills and
comprehension.1 Physical manifestations include decreased head
circumference in comparison to smoke-free controls.
According to a recent study conducted at Tygerberg Hospital,13
39% of pregnant women smoked (in contrast to the 22% of
pregnant women in a developed country such as the USA14).
The 1995 South African national survey found an increase in the
general smoking population of 1% per annum.15 The rate of
increase was noted to be highest among the coloured
population. Smoking prevalence in the coloured population
(59%) is notably higher than among Indians (36%), whites (35%)
and blacks (31%). It is of great concern that in an era of
preventive medicine the smoking population in South Africa is
growing, escalating the adverse effects pointed out in the text.
Decreasing the prevalence and initiation of smoking in
pregnancy would be the most effective method of reducing the
adverse effects of smoking in pregnancy,7 in this way directly
improving perinatal outcome.
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The theme for World No Tobacco Day on 31 May 2005 is
‘Health Professionals against Tobacco’. Doctors in South Africa
are missing clinical opportunities to help patients who use
tobacco, and recognising and taking advantage of these
opportunities will require changes in the education of medical
students.
In 1979, M A H Russell and his colleagues in London
published research that created a sensation in smoking
cessation circles.
1
The study demonstrated that following
simple but firm advice to stop smoking from their general
practitioner, about 5% of smokers would quit. While the impact
of an individual GP may be small, collective action by the
profession would yield impressive change. Russell et al.
calculated that if all GPs in Britain gave anti-smoking advice to
their patients on at least one occasion, half a million patients
would stop smoking as a direct result – a target unlikely to be
matched if the 50 specialised smoking cessation clinics then
operating in the UK were increased to 10 000.
In South Africa, if our 200 000 registered health professionals
each helped one patient to stop smoking per month this would
produce 2.4 million ex-smokers a year and dramatically reduce
the numbers of smokers in this country. However, harnessing
the power of doctors to turn smokers into ex-smokers remains
an elusive goal in public health.
On 31 May, World No Tobacco Day, the World Health
Organization once again focuses on the role of health
professionals in tobacco control. Health workers, and especially
doctors, are in a unique position to help smokers. Patients
expect to get information, help and guidance from their doctor
on health matters. It is the doctor who is most trusted and
whose advice has the most impact upon people’s health.
Yet anecdotal evidence suggests that the average GP seldom
raises the issue of smoking during a consultation.  GPs
frequently do not know which of their patients smoke, and as
often fail to advise them to stop even when this should be part
of the treatment. There are several reasons why doctors have
failed to act. Perhaps the most important is that many doctors,
even those deeply concerned about the harm caused by
tobacco, feel powerless to influence their patient’s behaviour.
Many believe they lack expertise, and that they have little to
offer their patients who need help.
This pessimism is misplaced. A doctor can both motivate and
help people stop smoking. At the very least a doctor can refer
the patient who says ‘I’ve tried everything and nothing works’
to the Tobacco or Health Information Line (on (011) 720-3145)
for counselling.
The reluctance of doctors to act points to a deeper problem.
There is insufficient education for health professionals in this
area. In fact, the whole area of medical training is under
challenge. Doctors have been criticised for ‘practising 19th-
century medicine in the 21st century’.  It is argued that the
training of medical students has to change so that over time
doctors will move from the reactive care of individual patients
with acute illness to the proactive, planned and preventive care
of populations.
2
The WHO has suggested that training has to
be restructured to include a new set of competencies to help
health workers manage today’s most prevalent health
problems.
2
Among the new competencies required is helping people
deal with addictions, eating disorders and other lifestyle
problems. Currently no school of public health in South Africa
has a chair on addictions.  The University of the Witwatersrand
has a teaching block on tobacco control, but in the others
Educating medical students about tobacco
329-331  5/6/05  2:24 PM  Page 330
